GlaxoSmithKline news. Headlines for GSK.

GlaxoSmithKline News

Prices

Results Calendar charts

Charts

Watchlist

Share Tips

Here are all todays headlines related to GlaxoSmithKline News. If you wish to drill deeper to view past GlaxoSmithKline News items, follow the next 20 headlines link at the foot of the page.

Monday broker round-up

09-04-2018

BHP Billiton: Societe Generale upgrades to buy with a target price of 1,600p.

GSK company wins European panel approval for two-drug HIV treatment

27-03-2018

GlaxoSmithKline's specialist HIV company ViiV Healthcare won approval from the European Medicines Agency for its two drug regimen to treat the AIDS causing disease.

Glaxo buys Novartis stake in consumer health venture for $13bn

27-03-2018

GlaxoSmithKline (GSK) on Tuesdsay said it had agreed to buy Novartis' 36.5% stake in their Consumer Healthcare Joint Venture for $13bn (£9.2bn).

Friday broker round-up

23-03-2018

Mitie Group: Barclays upgrades to overweight with a target price of 180p.

GSK gets approval for Shingrix in Europe and Japan

23-03-2018

GlaxoSmithKline announced on Friday that the European Commission has approved Shingrix for the prevention of shingles (herpes zoster) and post-herpetic neuralgia (PHN) in adults aged 50 years or older.

GlaxoSmithKline confirms it's no longer interested in Pfizer

23-03-2018

GlaxoSmithKline confirmed on Friday that it has withdrawn from the process relating to Pfizer's Consumer Healthcare business.

Reckitt Benckiser quits bidding for Pfizer's consumer healthcare arm

22-03-2018

Reckitt Benckiser has ended discussions with Pfizer about buying elements of the US company's consumer healthcare business.

Boost for GSK as Hikma, Vectura expect 2020 launch for generic Advair

12-03-2018

Generic drug-maker Hikma Pharmaceuticals will carry out a clinical trial of its generic version of GlaxoSmithKline's Advair Diskus asthma drug after consultation with the US drug regulator.

GlaxoSmithKline's Relvar Ellipta gets updated label in EU

08-03-2018

GlaxoSmithKline and its partner Innoviva announced on Thursday that the European Commission has approved a label update for the use of once-daily Relvar Ellipta (fluticasone furoate/vilanterol, FF/VI).

Director dealings: GlaxoSmithKline directors offload shares

20-02-2018

Several directors of GlaxoSmithKline offloaded shares in the healthcare giant on Tuesday in order to meet certain tax liabilities.

Kepler upgrades Glaxo, says worst-case scenario priced in

09-02-2018

Kepler Cheuvreux upped its stance on pharmaceuticals giant GlaxoSmithKline to 'hold' from 'reduce' on Friday, lifting the price target to 1,360p from 1,340p as it said the worst-case scenario for the stock was now priced in

GSK's HIV asset ViiV launches major new study

08-02-2018

ViiV Healthcare, the specialist HIV company majority owned by GlaxoSmithKline, with Pfizer and Shionogi as shareholders, announced the start of a major study on Thursday.

Thursday broker round-up

08-02-2018

Rangold resources: HSBC upgrades to buy with a target price of 7,700p.

GSK's ViiV claims Gilead Sciences infringed on its patents

08-02-2018

ViiV Healthcare, the global specialist HIV company majority-owned by GlaxoSmithKline, with Pfizer and Shionogi as shareholders, announced on Thursday that it has filed patent infringement litigation against Gilead Sciences over bictegravir in the United States and Canada.

GSK provides reassuring prognosis for annual dividend

07-02-2018

GlaxoSmithKline looked to put worries about its future dividend to bed as it reported 3% growth in sales and 4% in earnings per share at constant currency rates.

GSK's meningitis-B vaccine gets FDA fast-track boost

07-02-2018

A meningitis vaccine developed by GlaxoSmithKline has been given a 'breakthrough therapy' status by US drug regulators to fast-track its development to becoming a first-line treatment.

GSK gets two positive recommendation from EU medicines agency

26-01-2018

Pharmaceutical company GlaxoSmithKline have received positive recommendations from the European medicines approval committee for two treatments on Friday, one an inhaled asthma treatment and the other for prevention of shingles.

Wednesday broker round-up

17-01-2018

Big Yellow Group: Berenberg upgrades to buy with a target price of 920p.

Next 20 headlines >>

Stock News headlines are gathered from financial news sources around the web. Views and opinions on each item are from their respective authors and website. They are not opinions of LiveCharts.co.uk

Get a free widget for your website with our latest headlines.

You can now add our live prices and new headlines to your website.The news widget features quotes for Oil prices, spot Gold price and Indices plus a choice of news channel for healines.

Visit our widget builder